STAT's Readout LOUD podcast discusses Pfizer's woes, explains RFK Jr.'s 'MAHA' campaign, and mulls the latest about the Novo ...
Activist investor Starboard met with Pfizer last week. Here's what went down, according to the hedge fund's cofounder and CEO ...
Dick Durbin (D-Ill.) demanded answers from Pfizer and Eli Lilly about their relationships with the telehealth prescribers ...
The activist investor claims Pfizer failed to capitalize on the windfall earned from its COVID-19 vaccine and, in the process, destroyed tens of billions of dollars in market value.
With Pfizer’s stock down sharply, an activist investor is pushing for CEO Albert Bourla to improve performance.
The U.S. Food and Drug Administration on Tuesday approved Pfizer's RSV vaccine for the prevention of lower respiratory tract ...
Leif Johansson, chairman of AstraZeneca, commented on the news: "We note Pfizer's confirmation that it no longer intends to make an offer for AstraZeneca. We welcome the opportunity to continue ...
Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...
A spokesman for the hedge fund had no comment on the board news. Pfizer, which has a market capitalization of $165 billion, said it began its search for a new board member in May. It named Buckley ...
covering some of the most notable news stories of the time. Beata Zawrzel / NurPhoto via Getty Images Pfizer is withdrawing all of its sickle cell disease drug, Oxbryta, worldwide because of ...
Wall Street expects a year-over-year increase in earnings on higher revenues when Pfizer (PFE) reports results for the quarter ended September 2024. While this widely-known consensus outlook is ...
(Bloomberg) -- Pfizer Inc. has raised about £2.4 billion ... according to terms of the deal seen by Bloomberg News. The oversubscribed offering was priced at £3.80 per share, a discount of ...